5-APB

From Wikipedia, the free encyclopedia
5-APB
Systematic (IUPAC) name
5-(2-aminopropyl)benzofuran
Clinical data
Pregnancy cat. ?
Legal status Uncontrolled
Identifiers
CAS number 286834-80-8 N
ATC code None
PubChem CID 9837232
ChemSpider 8012953 YesY
Chemical data
Formula C11H13NO 
Mol. mass 175.23 g/mol
 N (what is this?)  (verify)

5-(2-aminopropyl)benzofuran or 1-benzofuran-5-ylpropan-2-amine (5-APB) is a triple monoamine reuptake inhibitor with Ki values of 180, 265 and 811 for NET, DAT and SERT respectively as well as being a potent agonist for the 5-HT2B receptor (Ki 14nM).[1] This agonism for 5-HT2B makes it likely that 5-APB would be cardiotoxic with long term use, as seen in other 5-HT2B agonists such as fenfluramine and MDMA. The subjective effects and structure-activity relationship suggest that 5-APB is also a monoamine releasing agent. Preliminary evidence suggests 5-APB is an inhibitor of the CYP2D6 enzyme.[2]

5-APB is commonly found as the succinate and hydrochloride salt. The hydrochloride salt is 10% more potent by mass and doses should be adjusted accordingly.

5-APB is also an agonist of the 5-HT2C receptor [3] as well as a triple monoamine reuptake inhibitor.[1] It has been sold as a designer drug since 2010.[4] Anecdotal reports from users suggest it has stimulant and empathogenic effects, but less psychedelic action than related compounds such as 6-APB and 5-APDB.[citation needed]

Detection

A forensic standard of 5-APB is available, and the compound has been posted on the Forendex website of potential drugs of abuse.[5] The US Department of Justice and DEA have also conducted studies concerning the detection of 5-APB.[6]

Effects

Users describe effects as euphoric. Largely, effects reported were similar to that of the drug MDA but not as strong.

See also

References

  1. 1.0 1.1 Iversen, L.; Gibbons, S.; Treble, R.; Setola, V.; Huang, X. P.; Roth, B. L. (2012). "Neurochemical profiles of some novel psychoactive substances". European Journal of Pharmacology. doi:10.1016/j.ejphar.2012.12.006. 
  2. "Inhibition of CYP2D6 by 5-APB". Retrieved 19 November 2013. 
  3. US patent 7045545, Karin Briner et al, "Aminoalkylbenzofurans as serotonin (5-HT(2c)) agonists", published 2000-01-19, issued 2006-16-03 
  4. EMCDDA–Europol 2010 Annual Report on the implementation of Council Decision 2005/387/JHA
  5. Southern Association of Forensic Scientists, http://forendex.southernforensic.org/index.php/detail/index/1135
  6. USDOJ/DEA, http://www.justice.gov/dea/pr/microgram-journals/2011/mj8-2_62-74.pdf
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.